Regulation of nicotinic acetylcholine receptor channel function by acetylcholinesterase inhibitors in rat hippocampal CA1 interneurons

Molecular Pharmacology

Volumn 66, Issue 3, 2004, Pages 658-666

  Fayuk, Dmitriy ^b   Yakel, Jerrel L ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

1,5 BIS(4 ALLYLDIMETHYLAMMONIUMPHENYL)PENTAN 3 ONE DIBROMIDE; ACETYLCHOLINE; ACETYLCHOLINESTERASE; CARBACHOL; CHOLINE; CHOLINESTERASE INHIBITOR; DYFLOS; GALANTAMINE; HUPERZINE A; NICOTINIC RECEPTOR; RECEPTOR SUBTYPE; TACRINE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; COGNITION; CONTROLLED STUDY; DESENSITIZATION; DRUG MECHANISM; HIPPOCAMPUS; INTERNEURON; KINETICS; NONHUMAN; OOCYTE; PATCH CLAMP; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; XENOPUS LAEVIS;

ANIMALS; CHOLINESTERASE INHIBITORS; ELECTROPHYSIOLOGY; FEMALE; GALANTAMINE; HIPPOCAMPUS; INTERNEURONS; ISOFLUROPHATE; OOCYTES; RATS; RECEPTORS, NICOTINIC; XENOPUS LAEVIS;

EID: 4944234184     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.000042     Document Type: Article

References (40)

1. Alkondon M and Albuquerque EX (1993) Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes. J Pharmacol Exp Ther 265:1455-1473.
2. Alkondon M, Pereira EF, and Albuquerque EX (1998) α-Bungarotoxin- and methyllycaconitine-sensitive nicotinic receptors mediate fast synaptic transmission in interneurons of rat hippocampal slices. Brain Res 810:257-263.
3. Austin L and Berry WK (1953) Two selective inhibitors of cholinesterase. Biochem J 54:695-700.
4. Bigbee JW, Sharma KV, Chan EL, and Bogler O (2000) Evidence for the direct role of acetylcholinesterase in neurite outgrowth in primary dorsal root ganglion neurons. Brain Res 861:354-362.
5. Bushnell PJ, Padilla SS, Ward T, Pope CN, and Olszyk VB (1991) Behavioral and neurochemical changes in rats dosed repeatedly with diisopropylfluorophosphate. J Pharmacol Exp Ther 256:741-750.
6. Canti C, Bodas E, Marsal J, and Solsona C (1998) Tacrine and physostigmine block nicotinic receptors in Xenopus oocytes injected with Torpedo electroplaque membranes. Eur J Pharmacol 363:197-202.
7. Chacon MA, Reyes AE, and Inestrosa NC (2003) Acetylcholinesterase induces neuronal cell loss, astrocyte hypertrophy and behavioral deficits in mammalian hippocampus. J Neurochem 87:195-204.
8. Cobb SE, Bulters DO, Suchak S, Riedel G, Morris RG, and Davies CH (1999) Activation of nicotinic acetylcholine receptors patterns network activity in the rodent hippocampus. J Physiol 518:131-140.
9. Court J, Martin-Ruiz C, Piggott M, Spurden D, Griffiths M, and Perry E (2001) Nicotinic receptor abnormalities in Alzheimer's disease. Biol Psychiatry 49:175-184.
10. Day T and Greenfield SA (2002) A non-cholinergic, trophic action of acetylcholinesterase on hippocampal neurones in vitro: molecular mechanisms. Neuroscience 111:649-656.
11. Decker MW and McGaugh JL (1991) The role of interactions between the cholinergic system and other neuromodulatory systems in learning and memory. Synapse 7:151-168.
12. De Ferrari GV, Canales MA, Shin I, Weiner LM, Silman I, and Inestrosa NC (2001) A structural motif of acetylcholinesterase that promotes amyloid β-peptide fibril formation. Biochemistry 40:10447-10457.
13. Descarries L, Gisiger V, and Steriade M (1997) Diffuse transmission by acetylcholine in the CNS. Prog Neurobiol 53:603-625.
14. Frazier CJ, Buhler AV, Weiner JL, and Dunwiddie TV (1998) Synaptic potentials mediated via alpha-bungarotoxin-sensitive nicotinic acetylcholine receptors in rat hippocampal interneurons. J Neurosci 18:8228-8235.
15. Gray R, Rajan AS, Radcliffe KA, Yakehiro M, and Dani JA (1996) Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature (Lond) 383:713-716.
16. Jones S, Sudweeks S, and Yakel JL (1999) Nicotinic receptors in the brain: correlating physiology with function. Trends Neurosci 22:555-561.
17. Jones S and Yakel JL (1997) Functional nicotinic ACh receptors on interneurones in the rat hippocampus. J Physiol 504:603-610.
18. 2+ regulation of nicotinic acetylcholine receptor channels in rat hippocampal CA1 neurons. J Neurosci 23:9024-9031.
19. Khiroug SS, Harkness PC, Lamb PW, Sudweeks SN, Khiroug L, Millar NS, and Yakel JL (2002) Rat nicotinic ACh receptor α7 and β2 subunits co-assemble to form functional heteromeric nicotinic receptor channels. J Physiol 540:425-434.
20. Levin ED (2002) Nicotinic receptor subtypes and cognitive function. J Neurobiol 53:633-640.
21. Maelicke A, Schrattenholz A, Samochocki M, Radina M, and Albuquerque EX (2000) Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer's disease. Behav Brain Res 113:199-206.
22. Massoulié J, Sussman J, Bon S, and Silman I (1993) Structure and functions of acetylcholinesterase and butyrylcholinesterase. Prog Brain Res 98:139-146.
23. McGehee DS and Role LW (1995) Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu Rev Physiol 57:521-546.
24. McQuiston AR and Madison DV (1999) Nicotinic receptor activation excites distinct subtypes of interneurons in the rat hippocampus. J Neurosci 19:2887-2896.
25. Papke RL, Bencherif M, and Lippiello P (1996) An evaluation of neuronal nicotinic acetylcholine receptor activation by quaternary nitrogen compounds indicates that choline is selective for the α7 subtype. Neurosci Lett 213:201-204.
26. Paterson D and Nordberg A (2000) Neuronal nicotinic receptors in the human brain. Prog Neurobiol 61:75-111.
27. Picciotto MR, Zoli M, Lena C, Bessis A, Lallemand Y, LeNovere N, Vincent P, Pich EM, Brulet P, and Changeux JP (1995) Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature (Lond) 374:65-67.
28. Prendergast MA, Terry AV Jr, and Buccafusco JJ (1997) Chronic, low-level exposure to diisopropylfluorophosphate causes protracted impairment of spatial navigation learning. Psychopharmacology (Berl) 129:183-191.
29. Prince RJ, Pennington RA, and Sine SM (2002) Mechanism of tacrine block at adult human muscle nicotinic acetylcholine receptors. J Gen Physiol 120:369-393.
30. Samochocki M, Hoffle A, Fehrenbacher A, Jostock R, Ludwig J, Christner C, Radina M, Zerlin M, Ullmer C, Pereira EF, et al. (2003) Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors. J Pharmacol Exp Ther 305:1024-1036.
31. Shao Z and Yakel JL (2000) Single channel properties of neuronal nicotinic ACh receptors in stratum radiatum interneurons of rat hippocampal slices. J Physiol 527:507-513.
32. Soreq H and Seidman S (2001) Acetylcholinesterase - new roles for an old actor. Nat Rev Neurosci 2:294-302.
33. Stone JD, Terry AV Jr, Pauly JR, Prendergast MA, and Buccafusco JJ (2000) Protractive effects of chronic treatment with an acutely sub-toxic regimen of diisopropylflurophosphate on the expression of cholinergic receptor densities in rats. Brain Res 882:9-18.
34. Sudweeks SN and Yakel JL (2000) Functional and molecular characterization of neuronal nicotinic ACh receptors in rat CA1 hippocampal neurons. J Physiol 527:515-528.
35. Terry AV Jr and Buccafusco JJ (2003) The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development. J Pharmacol Exp Ther 306:821-827.
36. Upchurch M and Wehner JM (1987) Effects of chronic diisopropylfluorophosphate treatment on spatial learning in mice. Pharmacol Biochem Behav 27:143-151.
37. Vogt KE and Regehr WG (2001) Cholinergic modulation of excitatory synaptic transmission in the CA3 area of the hippocampus. J Neurosci 21:75-83.
38. Volpicelli LA and Levey AI (2004) Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus. Prog Brain Res 145:59-66.
39. Zangara A (2003) The psychopharmacology of huperzine A: an alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer's disease. Pharmacol Biochem Behav 75:675-686.
40. Zwart R, van Kleef RG, Gotti C, Smulders CJ, and Vijverberg HP (2000) Competitive potentiation of acetylcholine effects on neuronal nicotinic receptors by acetylcholinesterase-inhibiting drugs. J Neurochem 75:2492-2500.